Presentation TCT 2014 Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX Presenter: Deepak Bhatt September 16, 2014
Presentation TCT 2014 Feasibility Of Carotid Artery Placement Of The Novel Impella Pediatric Prototype Presenter: Melissa Webb September 16, 2014
Presentation TCT 2014 Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data Presenter: Khusrow Niazi September 16, 2014
Presentation TCT 2014 Coarctation Stenting Through the Carotid Approach in Neonates and Infants_ Presenter: Carlos Pedra September 16, 2014
Presentation TCT 2014 Comparison of sirolimus-eluting stents with biodegradable polymer versus zotarolimus-eluting stents with durable polymer assessed by optical coherence tomography: The ALSTER-OCT___ Presenter: Christian Heeger September 16, 2014
Presentation TCT 2014 Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk Presenter: George Hanzel September 16, 2014
Presentation TCT 2014 Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients Presenter: Ferdinando Varbella September 16, 2014
Presentation TCT 2014 Predictors For Tissue Embolization During Transcatheter Aortic Valve Implantation Presenter: Ramon Rodriguez-Olivares September 16, 2014
Presentation TCT 2014 VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_ Presenter: Jos? Mar?a Cubero G?mez September 16, 2014
Presentation TCT 2014 Determinants of Left Ventricular Mass Regression in Patients with Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation Presenter: Adaya Weissler-Snir September 16, 2014